Global EPA and DHA Market is Estimated To Witness High Growth Owing To Rising Demand for Omega-3 Fatty Acids
![]() |
EPA and DHA Market |
The global EPA and DHA market is estimated to be
valued at US$ 1,626.10 Mn in 2022
and is expected to exhibit a CAGR of
6.76% over the forecast period 2022-2030, as highlighted in a new report
published by Coherent Market Insights.
Market Overview:
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are omega-3 fatty
acids commonly found in fish oil and certain algae. These fatty acids are
essential for the proper functioning of the human body and have been linked to
numerous health benefits, including cardiovascular health, brain development,
and immune function. The increasing awareness about the importance of omega-3
fatty acids in maintaining overall health has led to a growing demand for EPA
and DHA supplements and functional foods.
Market Key Trends:
One key trend driving the growth of the EPA
And DHA Market is the rising demand for omega-3 fatty acids in the
pharmaceutical industry. EPA and DHA have been shown to have anti-inflammatory
properties and can help reduce the risk of chronic diseases such as heart
disease, arthritis, and certain types of cancer. This has led to an increased
incorporation of EPA and DHA in pharmaceutical formulations, such as
cardiovascular drugs and supplements. For example, Lovaza, a prescription
omega-3 fatty acid formulation, is used to treat high triglyceride levels. The
demand for EPA and DHA in the pharmaceutical industry is expected to drive
market growth during the forecast period.
PEST Analysis:
Political: The regulatory landscape for omega-3 fatty acids varies across
different regions. For example, in the United States, the Food and Drug Administration
(FDA) has approved certain omega-3 fatty acid formulations as prescription
drugs, while in other regions, they are classified as dietary supplements.
Economic: The increasing disposable income and growing health consciousness
among consumers are driving the demand for EPA and DHA supplements and
functional foods.
Social: The rising awareness about the health benefits of omega-3 fatty acids
and the importance of a balanced diet have fueled the demand for EPA and DHA
products among health-conscious consumers.
Technological: Advancements in extraction and purification technologies have
made it easier to obtain high-quality EPA and DHA from fish oil and algae
sources, ensuring the purity and efficacy of the products.
Key Takeaways:
1. The global EPA
And DHA Market is expected to witness high growth, exhibiting a CAGR of
6.76% over the forecast period, due to increasing awareness about the health
benefits of omega-3 fatty acids.
2. North America is expected to dominate the global EPA and DHA market, owing
to the high consumption of omega-3 supplements and functional foods in the
region.
3. Key players operating in the global EPA and DHA market include Koninklijke
DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV,
Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Clover Corporation
Ltd, Croda International PLC, Novotech Nutraceuticals, and Polaris.
In conclusion, the global EPA and DHA market is projected to grow significantly
over the forecast period. The rising demand for omega-3 fatty acids in the
pharmaceutical industry, coupled with increasing health awareness among
consumers, is fueling market growth. With advancements in technology and
increasing availability of high-quality EPA and DHA products, the market is
expected to witness sustained growth in the coming years.
Comments
Post a Comment